Previous 10 | Next 10 |
ESSA Pharma Inc. (EPIX) is expected to report $-0.17 for Q1 2024 QuidelOrtho Corp Com (QDEL) is expected to report $2.01 for Q4 2023 FaZe Holdings Inc. (FAZE) is expected to report for Q4 2023 Portsmouth Square, Inc. (PRSI) is expected to report for Q2 2024 Similarweb Ltd. (SMWB) ...
EDEN PRAIRIE, Minn., Feb. 08, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, will host a confe...
2023-12-15 10:00:27 ET More on Health Care Select Sector SPDR Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble Health Care Select Sector Fund ETF: Riding The Healthcare Boom For further details see: Myomo, Aileron...
2023-12-14 18:30:06 ET NeuroOne Medical Technologies Corporation (NMTC) Q4 2023 Results Conference Call December 14, 2023 05:00 PM ET Company Participants Dave Rosa - CEO Ron McClurg - CFO Conference Call Participants Ben Haynor - Alliance Global Partners...
2023-12-14 16:25:30 ET More on NeuroOne Medical Technologies NeuroOne: A Hidden Contender Against ClearPoint In The Brain Drug Delivery Arena NeuroOne receives FDA 510(k) clearance to market OneRF Ablation System Seeking Alpha’s Quant Rating on NeuroOne Medica...
EDEN PRAIRIE, Minn., Dec. 14, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announces i...
IMV Inc. (IMVIQ) is expected to report for Q3 2023 Orbit International Corp. (ORBT) is expected to report for quarter end 2023-09-30 PLx Pharma Winddown Corp. (PLXPQ) is expected to report for quarter end 2023-09-30 Advantage Energy Ltd (AAVVF) is expected to report for Q1 2024 We...
NeuroOne Medical Technologies Corporation (NMTC) is expected to report for quarter end 2023-09-30
2023-12-11 09:00:41 ET More on NeuroOne Medical Technologies NeuroOne: A Hidden Contender Against ClearPoint In The Brain Drug Delivery Arena Seeking Alpha’s Quant Rating on NeuroOne Medical Technologies Historical earnings data for NeuroOne Medical Technologi...
First FDA-cleared thin-film, sEEG-guided RF system capable of both recording electrical activity and ablating nervous tissue with the added benefit of temperature control; Marks the Company’s third FDA 510(k)-cleared device Potential for transformative improvement in neurosurge...
News, Short Squeeze, Breakout and More Instantly...
NeuroOne Medical Technologies Corporation Company Name:
NMTC Stock Symbol:
OTCMKTS Market:
Five ablations performed successfully in one patient Procedure performed at patient’s bedside saving time and cost associated with the operating room EDEN PRAIRIE, Minn., June 25, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ( ...
ICD-10-PCS code for first to market, FDA-cleared thin-film, sEEG-guided RF ablation system effective October 1, 2024 Specific procedure code positions OneRF ™ Ablation System for broader adoption and awareness throughout the healthcare system EDEN ...
EDEN PRAIRIE, Minn., May 14, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological d...